These findings highlight a critical role for tumor cell-intrinsic STING in the anti-tumor innate immune responses mediated by STING agonism and provide the rationale for tumor cell-targeted STINGa ADCs as an effective immunotherapy strategy. This evidence concerns the gene STING1 and neoplasm.